Quadrant Capital Group’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $227K | Buy |
13,277
+12,706
| +2,225% | +$217K | 0.01% | 1252 |
|
2025
Q1 | $36.4K | Sell |
571
-271
| -32% | -$17.3K | ﹤0.01% | 1831 |
|
2024
Q4 | $102K | Sell |
842
-24
| -3% | -$2.92K | 0.01% | 1037 |
|
2024
Q3 | $108K | Buy |
866
+303
| +54% | +$37.8K | 0.01% | 1024 |
|
2024
Q2 | $89K | Buy |
563
+482
| +595% | +$76.2K | 0.01% | 1078 |
|
2024
Q1 | $10.5K | Buy |
81
+12
| +17% | +$1.55K | ﹤0.01% | 2088 |
|
2023
Q4 | $6.65K | Buy |
69
+31
| +82% | +$2.99K | ﹤0.01% | 2199 |
|
2023
Q3 | $4.61K | Buy |
38
+1
| +3% | +$121 | ﹤0.01% | 2198 |
|
2023
Q2 | $4.24K | Sell |
37
-90
| -71% | -$10.3K | ﹤0.01% | 2244 |
|
2023
Q1 | $17.5K | Buy |
127
+95
| +297% | +$13.1K | ﹤0.01% | 1760 |
|
2022
Q4 | $4.15K | Sell |
32
-25
| -44% | -$3.24K | ﹤0.01% | 2246 |
|
2022
Q3 | $6K | Sell |
57
-89
| -61% | -$9.37K | ﹤0.01% | 2094 |
|
2022
Q2 | $11K | Sell |
146
-163
| -53% | -$12.3K | ﹤0.01% | 1623 |
|
2022
Q1 | $24K | Sell |
309
-465
| -60% | -$36.1K | ﹤0.01% | 1251 |
|
2021
Q4 | $70K | Sell |
774
-7
| -0.9% | -$633 | 0.01% | 793 |
|
2021
Q3 | $72K | Buy |
781
+600
| +331% | +$55.3K | 0.01% | 736 |
|
2021
Q2 | $14K | Buy |
181
+142
| +364% | +$11K | ﹤0.01% | 1400 |
|
2021
Q1 | $3K | Sell |
39
-33
| -46% | -$2.54K | ﹤0.01% | 1988 |
|
2020
Q4 | $12K | Buy |
72
+30
| +71% | +$5K | ﹤0.01% | 1312 |
|
2020
Q3 | $6K | Sell |
42
-3
| -7% | -$429 | ﹤0.01% | 1484 |
|
2020
Q2 | $7K | Sell |
45
-186
| -81% | -$28.9K | ﹤0.01% | 1518 |
|
2020
Q1 | $22K | Buy |
231
+218
| +1,677% | +$20.8K | ﹤0.01% | 1242 |
|
2019
Q4 | $1K | Buy |
+13
| New | +$1K | ﹤0.01% | 2353 |
|
2019
Q3 | – | Sell |
-389
| Closed | -$58K | – | 2382 |
|
2019
Q2 | $58K | Sell |
389
-52
| -12% | -$7.75K | 0.01% | 1149 |
|
2019
Q1 | $51K | Buy |
+441
| New | +$51K | 0.01% | 1208 |
|
2018
Q4 | – | Sell |
-6
| Closed | – | – | 2287 |
|
2018
Q3 | $0 | Buy |
+6
| New | – | ﹤0.01% | 2185 |
|